Introduction
Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases and exhibits diverse molecular subtypes. Computational analysis supports patient stratification and biomarker discovery. Explore expert-level studies on NSCLC immune profiling, gene expression, and immunotherapy response prediction.
